Global Artemisinin and Derivatives Market Growth 2024-2030

Global Artemisinin and Derivatives Market Growth 2024-2030

Artemisinin is a sesquiterpene lactone compound derived from the sweet wormwood plant, scientifically known as Artemisia annua. It is a natural product with potent antimalarial properties, making it a key component in the treatment of malaria. Artemisinin and its derivatives are crucial compounds primarily used in the treatment of malaria, showcasing potent antimalarial properties. Common artemisinin derivatives include artemether, artesunate, and dihydroartemisinin.

The global Artemisinin and Derivatives market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Artemisinin and Derivatives Industry Forecast” looks at past sales and reviews total world Artemisinin and Derivatives sales in 2023, providing a comprehensive analysis by region and market sector of projected Artemisinin and Derivatives sales for 2024 through 2030. With Artemisinin and Derivatives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin and Derivatives industry.

This Insight Report provides a comprehensive analysis of the global Artemisinin and Derivatives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin and Derivatives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisinin and Derivatives market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin and Derivatives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin and Derivatives.

United States market for Artemisinin and Derivatives is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Artemisinin and Derivatives is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Artemisinin and Derivatives is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Artemisinin and Derivatives players cover KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Ipca Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin and Derivatives market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Artemisinin
Artemether
Artesunate
Dihydroartemisinin

Segmentation by Application:
Antimalarial Drugs
Antitumor and Anti-inflammatory Drugs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
KPC Pharmaceuticals
Guilin Nantang Pharmaceutical
Chongqing Kerui Nanhai Pharmaceutical
Sichuan Xieli Pharmaceutical
Ipca Laboratories
Aqre Group
Cerata Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artemisinin and Derivatives market?

What factors are driving Artemisinin and Derivatives market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artemisinin and Derivatives market opportunities vary by end market size?

How does Artemisinin and Derivatives break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.